Greenwich LifeSciences GLSI Insider Ownership

NASDAQ GLSI
$18.38 -0.21 (-1.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insider Holdings by Owner

6.98Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
66.57%
▲+0.050% pp QoQ
Shares Held by Insiders
9.70Mn
filed for Sep 2026
▲+0.08% QoQ
Shares Outstanding
14.57Mn
14,565,230 shares
Direct Holdings
6.98Mn
Indirect: 2.71Mn
Net Shares Traded (QoQ)
+7.30K
net buying in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

GLSI's three largest insider shareholders as of September 29, 2026 are Snehal Patel (Ceo And Cfo, 5.61Mn shares), Snehal Patel (Ceo And Cfo, 2.71Mn shares), David Mcwilliams (Director, 620.30K shares).

Form 4 Holdings

Insiders Holding GLSI

Insiders 5
Shares held 6.98Mn
Of outstanding 47.94%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Snehal Patel Ceo And Cfo 5,611,402 0 5,611,402 80.4% 30 Jul, 2026
2 David Mcwilliams Director 620,301 0 620,301 8.9% 15 Dec, 2021
3 Kenneth Hallock Director 397,304 0 397,304 5.7% 24 Jan, 2022
4 Jaye Thompson Vp Clinical Reg Affairs 264,148 0 264,148 3.8% 25 Nov, 2024
5 Frank Joseph Daugherty Chief Medical Officer 90,121 0 90,121 1.3% 26 Apr, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

190 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
28 Jul, 2026 Snehal Patel Ceo And Cfo Acquired P 1,500 $13.59 $20.39K 5,610,702 Direct
29 Jul, 2026 Snehal Patel Ceo And Cfo Acquired P 700 $13.10 $9.17K 5,611,402 Direct
27 Jul, 2026 Snehal Patel Ceo And Cfo Acquired P 1,500 $13.62 $20.43K 5,609,202 Direct
23 Jul, 2026 Snehal Patel Ceo And Cfo Acquired P 2,500 $13.14 $32.85K 5,606,602 Direct
24 Jul, 2026 Snehal Patel Ceo And Cfo Acquired P 1,100 $12.88 $14.17K 5,607,702 Direct
13 Jan, 2026 Snehal Patel Ceo And Cfo Acquired P 1,800 $29.83 $53.69K 5,604,102 Direct
12 Jan, 2026 Snehal Patel Ceo And Cfo Acquired P 2,900 $27.54 $79.87K 5,602,302 Direct
31 Dec, 2025 Snehal Patel Ceo And Cfo Acquired P 4,300 $21.36 $91.85K 5,599,402 Direct
30 Dec, 2025 Snehal Patel Ceo And Cfo Acquired P 2,900 $21.73 $63.02K 5,595,102 Direct
18 Dec, 2025 Snehal Patel Ceo And Cfo Acquired P 4,100 $12.62 $51.74K 5,592,202 Direct
25 Nov, 2025 Snehal Patel Ceo And Cfo Acquired P 4,600 $8.37 $38.50K 5,588,102 Direct
13 Nov, 2025 Snehal Patel Ceo And Cfo Acquired A 100,000 $0.00 $0 2,347,462 Direct
07 Nov, 2025 Snehal Patel Ceo And Cfo Acquired P 10,600 $8.43 $89.36K 5,583,502 Direct
31 Oct, 2025 Snehal Patel Ceo And Cfo Acquired P 2,300 $9.26 $21.30K 5,572,902 Direct
25 Apr, 2025 Snehal Patel Ceo And Cfo Acquired P 3,600 $9.88 $35.57K 5,570,602 Direct
17 Apr, 2025 Snehal Patel Ceo And Cfo Acquired P 5,400 $8.98 $48.49K 5,567,002 Direct
07 Apr, 2025 Snehal Patel Ceo And Cfo Acquired P 3,600 $9.10 $32.76K 5,561,602 Direct
04 Apr, 2025 Snehal Patel Ceo And Cfo Acquired P 5,500 $8.73 $48.02K 5,558,002 Direct
10 Jan, 2025 Snehal Patel Ceo And Cfo Acquired P 2,500 $12.51 $31.28K 5,552,502 Direct
06 Jan, 2025 Snehal Patel Ceo And Cfo Acquired P 1,100 $13.31 $14.64K 5,548,202 Direct